BARCELONA -- A novel antibody-based drug targeting the CD40 ligand helped close to half of patients with treatment-refractory ...

Biogen Inc. (NASDAQ:BIIB) is one of the 11 most profitable NASDAQ stocks to buy now. On June 12, UCB and Biogen presented ...

The Green Steel Market, valued at USD 7.4 billion in 2024, is expected to reach USD 19.4 billion by 2029, growing at a CAGR ...

United Commercial Bank PLC (UCB) has launched a microservices-based open API banking platform in Bangladesh following an ...

UCB and Biogen's lupus candidate showed strong Phase 3 results, including fatigue improvement and higher remission versus ...

Belgium’s largest drugmaker UCB has announced plans for a significant investment in a new, state-of-the-art biologics ...

Amid the threat of pharmaceutical tariffs from President Donald Trump, recent months have seen multibillion-dollar U.S.

Full results from the first phase 3 trial of UCB and Biogen's anti-CD40L antibody dapirolizumab pegol (DZP) in systemic lupus ...

Alongside the data in PsA, UCB will present at EULAR new results demonstrating that Bimzelx delivered sustained clinical ...

Mumbai: National Urban Co-operative Finance & Development Corporation (NUCFDC) has launched 'Sahakar PaathShaala,' a national-level training and capacity-building program for Urban Cooperative Banks ...

"These data, alongside our other EULAR data presentations of dapirolizumab pegol § in systemic lupus erythematosus and romosozumab in osteoporosis, reflect UCB's commitment to offering ...